Siah: a promising anticancer target.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23455005.
- Also identified by DOI 10.1158/0008-5472.CAN-12-4348.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Siah ubiquitin ligases play important roles in a number of signaling pathways involved in the progression and spread of cancer in cell-based models, but their role in tumor progression remains controversial. Siah proteins have been described to be both oncogenic and tumor suppressive in a variety of patient cohort studies and animal cancer models. This review collates the current knowledge of Siah in cancer progression and identifies potential methods of translation of these findings into the clinic. Furthermore, key experiments needed to close the gaps in our understanding of the role Siah proteins play in tumor progression are suggested.
Medical subject headings
- Neoplasms
- Nuclear Proteins
- Ubiquitin-Protein Ligases